Advanced search

International, randomized phase 3 study results : Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM))

(2016) ONCOLOGY RESEARCH AND TREATMENT. 39(suppl. 3). p.6-6
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Burger, J, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, et al. 2016. “International, Randomized Phase 3 Study Results : Ibrutinib Versus Chlorambucil in Patients 65 Years and Older with Treatment-naive CLL (RESONATE-2 (TM)).” In Oncology Research and Treatment, 39:6–6.
APA
Burger, J, Tedeschi, A., Barr, P., Robak, T., Owen, C., Ghia, P., Bairey, O., et al. (2016). International, randomized phase 3 study results : Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM)). ONCOLOGY RESEARCH AND TREATMENT (Vol. 39, pp. 6–6). Presented at the Annual conference of the German, Austrian and Swiss Societies for Haematology and Medical Oncology.
Vancouver
1.
Burger J, Tedeschi A, Barr P, Robak T, Owen C, Ghia P, et al. International, randomized phase 3 study results : Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM)). ONCOLOGY RESEARCH AND TREATMENT. 2016. p. 6–6.
MLA
Burger, J, A Tedeschi, PM Barr, et al. “International, Randomized Phase 3 Study Results : Ibrutinib Versus Chlorambucil in Patients 65 Years and Older with Treatment-naive CLL (RESONATE-2 (TM)).” Oncology Research and Treatment. Vol. 39. 2016. 6–6. Print.
@inproceedings{8509429,
  articleno    = {abstract V34},
  author       = {Burger, J and Tedeschi, A and Barr, PM and Robak, T and Owen, C and Ghia, P and Bairey, O and Hillmen, P and Bartlett, NL and Li, J and Simpson, D and Grosicki, S and Devereux, S and Mccarthy, H and Coutre, S and Quach, H and Gaidano, G and Maslyak, Z and Stevens, DA and Janssens, A and Offner, Fritz and Mayer, J and O'Dwyer, M and Hellmann, A and Schuh, A and Siddiqi, T and Polliack, A and Tam, CS and Suri, D and Cheng, M and Clow, F and Styles, L and James, DF and Kipps, TJ},
  booktitle    = {ONCOLOGY RESEARCH AND TREATMENT},
  issn         = {2296-5270},
  language     = {eng},
  location     = {Leipzig, Germany},
  number       = {suppl. 3},
  pages        = {abstract V34:6--abstract V34:6},
  title        = {International, randomized phase 3 study results : Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM))},
  volume       = {39},
  year         = {2016},
}

Web of Science
Times cited: